BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8221670)

  • 21. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent amplification of two gene clusters on chromosome 4 in rat endometrial cancer: identification and molecular characterization.
    Walentinsson A; Helou K; Wallenius V; Hedrich HJ; Szpirer C; Levan G
    Cancer Res; 2001 Nov; 61(22):8263-73. PubMed ID: 11719459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary.
    Filmus JE; Buick RN
    Cancer Res; 1985 Sep; 45(9):4468-72. PubMed ID: 4028028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational heterogeneity among individual tumors in a case of multiple primary malignancy of the colon.
    Terunuma H; Hayakashi T; Tsuneyoshi T; Fujita M; Kino I; Baba S
    Jpn J Clin Oncol; 1993 Dec; 23(6):350-5. PubMed ID: 8283788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
    Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
    Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
    Bouchalová K; Trojanec R; Kolár Z; Cwiertka K; Cernáková I; Mihál V; Hajdúch M
    Neoplasma; 2006; 53(5):393-401. PubMed ID: 17013533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of oncogenes in cancer metastases.
    Thorgeirsson UP; Turpeenniemi-Hujanen T; Talmadge JE; Liotta LA
    Prog Clin Biol Res; 1986; 212():77-95. PubMed ID: 3520581
    [No Abstract]   [Full Text] [Related]  

  • 29. Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C; Yu M; Shan L; Snyderwine EG
    Oncogene; 2003 Feb; 22(8):1253-60. PubMed ID: 12606953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of Ras mutations in rat DMBA-induced mammary tumors.
    Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
    Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathology of mammary tumours in female rats treated with 1-methyl-1-nitrosourea.
    Liska J; Galbavy S; Macejova D; Zlatos J; Brtko J
    Endocr Regul; 2000 Jun; 34(2):91-6. PubMed ID: 10911410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathology of metastasizing tumors in nitrosomethyl urea-induced rat mammary carcinoma.
    Ghosh L; Nassauer J; Faiferman I; Ghosh BC
    J Surg Oncol; 1981; 18(1):21-6. PubMed ID: 7289615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
    Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D
    Oncogene; 2000 Feb; 19(8):1052-8. PubMed ID: 10713689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal models for breast cancer.
    Sukumar S; McKenzie K; Chen Y
    Mutat Res; 1995 Dec; 333(1-2):37-44. PubMed ID: 8538634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The G and C banding chromosome patterns of the transplantable mammary adenocarcinoma in mice].
    Ling LH
    Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):423-5. PubMed ID: 3869923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathology of breast lesions induced in BUF rats of varying ages by ingestion of N-4-(4'-fluorobiphenyl) acetamide.
    Stromberg K; Reuber MD
    J Natl Cancer Inst; 1975 May; 54(5):1223-30. PubMed ID: 1168728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructure of the hormone-dependent N-nitrosomethylurea-induced mammary carcinoma of the rat.
    Tseng MT
    Cancer Res; 1980 Sep; 40(9):3112-5. PubMed ID: 7427929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations.
    Cha RS; Thilly WG; Zarbl H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3749-53. PubMed ID: 8170982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosome alterations in rat mammary tumor progression.
    Aldaz CM; Gollahon LS; Chen A
    Prog Clin Biol Res; 1992; 376():137-53. PubMed ID: 1528918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.